Insider trading

Period: 120 months Stock: RXST Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

14 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

14 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

14 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

14 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
14 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
14 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

14 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
3 May 2024
Kurtz Ronald M MD President & CEO · indirect
Sold on a plan
$2.41M 40,000 at 60.15
5.0%
Planned (10b5-1)
1 Feb 2024
LINK WILLIAM J PHD Director · indirect
Sold at will 2×
$1.40M 28,250 at 49.67
53.8%
Sold half or more
26 Jan 2024
Thunen Shelley B Chief Financial Officer
Sold at will
$1.50M 31,772 at 47.11
82.4%
Sold half or more
8 Jan 2024
Kurtz Ronald M MD President & CEO · indirect
Sold on a plan 2×
$2.77M 62,500 at 44.25
7.2%
Planned (10b5-1)
8 Jan 2024
Warner Robert Keith Director · indirect
Sold on a plan 2×
$1.01M 23,750 at 42.69
100%
Sold half or more
14 Dec 2023
Kurtz Ronald M MD President & CEO · indirect
Sold on a plan 2×
$1.59M 40,000 at 39.70
4.3%
Planned (10b5-1)
29 Nov 2023
Tammenoms Bakker Juliet Director · indirect
Sold at will
$10.40M 349,245 at 29.77
100%
Sold half or more
28 Nov 2023
Tammenoms Bakker Juliet Director · indirect
Sold at will
$4.30M 145,068 at 29.62
29.3%
Not planned
15 Nov 2023
Tammenoms Bakker Juliet Director · indirect
Sold at will
$10.88M 400,000 at 27.20
44.7%
Not planned
14 Nov 2023
Tammenoms Bakker Juliet Director · indirect
Sold at will
$2.71M 100,000 at 27.13
10.1%
Not planned
10 Feb 2023
Tammenoms Bakker Juliet Director · indirect
Bought
$6.00M 480,000 at 12.50
96.0%
+96% of stake
3 Aug 2021
Tammenoms Bakker Juliet Director · indirect
Bought 2×
$10.00M 625,000 at 16.00
45.8%
First buy on file
3 Aug 2021
Kurtz Ronald M MD See Remarks
Bought
$2.00M 125,000 at 16.00
opened
First buy on file
3 Aug 2021
Corley Jesse Anderson Director · indirect
Bought
$1.25M 78,125 at 16.00
21.8%
First buy on file
Showing 1–14 of 14.